Doxofylline PCD Pharma Franchise Company
Cafoli Lifecare offers a dedicated Doxofylline PCD pharma franchise built on 9 formulations spanning tablets, syrup and injection. Every batch is produced at WHO-GMP certified facilities, giving franchise partners a respiratory portfolio they can promote confidently to chest physicians across India.
What is Doxofylline?
Doxofylline is a newer-generation xanthine bronchodilator used in the management of asthma and chronic obstructive pulmonary disease (COPD). It relaxes bronchial smooth muscle primarily through phosphodiesterase inhibition, and because it has weaker adenosine-receptor activity than theophylline, it is associated with a lower incidence of cardiac and gastric side effects. See its chemistry profile on PubChem.
Therapeutic Applications
Doxofylline is prescribed for bronchial asthma, COPD and conditions with reversible airway obstruction. Its availability as tablets, a paediatric-friendly syrup and an injection allows use across outpatient maintenance therapy and hospital settings. Prescriptions come mainly from pulmonologists, chest physicians, consultant physicians and general practitioners managing chronic respiratory patients.
Why Doxofylline is a High-Potential Molecule for Distributors
India carries one of the world's largest COPD and asthma burdens, and respiratory therapy is a repeat-prescription segment — patients stay on maintenance bronchodilators for years. Doxofylline occupies a distinct niche as a better-tolerated alternative to theophylline, so it retains steady prescriber loyalty while facing less brand crowding than inhaler categories. For a distributor, that means dependable monthly reorders across tablet, syrup and injection formats from a single molecule.
Why Choose Cafoli Lifecare
Cafoli Lifecare provides monopoly franchise rights for your territory, WHO-GMP certified manufacturing, DCGI-approved formulations, complete promotional inputs (visual aids, MR bags, samples) and the backing of a network of 1000+ franchise partners nationwide.
References
- PubChem: Doxofylline compound summary
- PubMed: Doxofylline clinical literature
Our formulations of Doxofylline find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: